3个月收入4.47亿元,君实PD-1追上来了?

医药魔方
27 Apr

4月25日,君实生物发布一季报:实现营收5.01亿元,同比增长31.46%;归母净利润自去年同期亏损2.83亿元变为亏损2.35亿元,扣非归母净利润则自去年同期亏损3.07亿元变为亏损2.39亿元。相对应的,君实生物一季度研发投入达3.51亿元,同比增长26.89%。值得关注的是,研发投入同比增长的前提下,君实生物实现营收大幅增长,亏损进一步收窄,主要得益于商业化药品销售收入的增长,尤其是核心产品...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10